FDA Sharply Restricts Avandia Use

A diabetes drug linked with a higher risk of heart attack will be sharply restricted starting November 18. The drug is rosiglitazone (Avandia). Nearly a year ago, a group of experts recommended that the drug be pulled from the market or remain with tighter limits. The U.S. Food and Drug Administration (FDA) imposed some new rules in September. It announced the full new policy this week. Avandia will be pulled from pharmacy shelves. It will be available only through specific mail-order pharmacies. Doctors will have to be certified in order to prescribe it. The drug will be limited to patients who are doing well on it now or can’t control their blood sugar with other drugs. They must be informed of the risks and choose to take Avandia anyway. The policies also apply to Avandamet and Avandaryl. These pills combine rosiglitazone with other diabetes drugs.

Content restricted. Requires subscription

Ask the doctor: Why does my heart sometimes feel like it stops, then starts up again with a jerk?

I am 92 and have atrial fibrillation and high blood pressure, both controlled by medication. Every so often when I am relaxing after dinner, my heart feels like it stops and then starts up again with a jerk. Is this something I should worry about?

Content restricted. Requires subscription

Ask the doctor: My defibrillator has never “fired.” Should I keep it or have it taken out?

My doctors recommended I get a defibrillator as “insurance,” but I have had it for eight years and it has never gone off. My doctor wants to put in a new battery. At age 86 I’d rather not. Could I just leave the device in place or have it taken out?

Content restricted. Requires subscription